Home
About Us
About Boan
Culture
Our History
Our Team
Responsibility
R&D
Technology platform
Boan Product Pipeline
Intellectual Property
Production capacity
Products
News
Careers
People Strategy
Employee Stories
Development
Job Opportunities
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Contact us
简
/
繁
/
EN
Highlights > Article details
Bears the same effects and similar safety and immunogenicity relative to RLD
2022.11.08
|
Boan Biotech,Shandong Boan Biotech, Boan Innovative Antibodies,Boan Biosimilar